Eton Pharmaceuticals (NASDAQ:ETON) reported its Q1 earnings results on Thursday, May 11, 2023 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Eton Pharmaceuticals beat estimated earnings by 28.57%, reporting an EPS of $-0.1 versus an estimate of $-0.14.
Revenue was up $3.13 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 4.88% drop in the share price the next day.
Here’s a look at Eton Pharmaceuticals’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.01 | -0.15 | 0.03 | -0.08 |
| EPS Actual | 0.04 | -0.12 | -0.06 | -0.21 |
| Revenue Estimate | 9.12M | 3.05M | 7.76M | 7.10M |
| Revenue Actual | 8.50M | 3.22M | 7.36M | 2.18M |
To track all earnings releases for Eton Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
